ERBB2 and breast carcinoma: In this retrospective study, we investigated associations between Akt expression, activation and compartmentalization and the efficacy of anti-HER2 targeted therapy on a model of metastatic HER2-positive breast cancer patients treated with monoclonal antibody against HER2 receptor, trastuzumab.